slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13.390 KRW | -2,69% | -1,18% | +16,74% |
29/01 | Zimbabwe start huis-aan-huis choleravaccinatiecampagne | RE |
2023 | Pop Biotechnologies en EuBiologics' Eucorvac-19 vaccin treft doel in Fase 3 studie | CI |
Omzet 2024 * | 116 mld. 83,75 mln. 78,42 mln. | Omzet 2025 * | 128 mld. 92,42 mln. 86,53 mln. | Marktkapitalisatie | 489 mld. 353 mln. 330 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 29 mld. 20,94 mln. 19,6 mln. | Nettowinst (verlies) 2025 * | 34 mld. 24,55 mln. 22,98 mln. | EV/omzet 2024 * | 4,33 x |
Nettoschuld 2024 * | 14 mld. 10,11 mln. 9,46 mln. | Nettoschuld 2025 * | 14 mld. 10,11 mln. 9,46 mln. | EV/omzet 2025 * | 3,93 x |
K/w-verhouding 2024 * |
16,6
x | K/w-verhouding 2025 * |
14,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,14% |
1 dag | -2,69% | ||
1 week | -1,18% | ||
Lopende maand | +10,48% | ||
1 maand | +10,48% | ||
3 maanden | +23,18% | ||
6 maanden | +44,60% | ||
Lopend jaar | +16,74% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yeong-Ok Baek
CEO | Chief Executive Officer | 61 | 01-01-05 |
Suk-Keun Choi
DFI | Director of Finance/CFO | 57 | 01-08-10 |
Kyeong-Ho Min
BRD | Director/Board Member | 55 | 01-12-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Suk-Keun Choi
DFI | Director of Finance/CFO | 57 | 01-08-10 |
Yeong-Ok Baek
CEO | Chief Executive Officer | 61 | 01-01-05 |
Kyeong-Ho Min
BRD | Director/Board Member | 55 | 01-12-10 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 13.390 | -2,69% | 385 803 |
29-04-24 | 13.760 | -1,08% | 424 525 |
26-04-24 | 13.910 | +0,58% | 859 800 |
25-04-24 | 13.830 | +2,90% | 681 143 |
24-04-24 | 13.440 | -1,18% | 538 128 |
slotkoers Korea S.E., 30 april 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,74% | 353 mln. | |
-4,24% | 86,85 mld. | |
+2,76% | 40,16 mld. | |
-16,07% | 31,28 mld. | |
+57,86% | 25,27 mld. | |
-15,58% | 15,33 mld. | |
-9,12% | 11,96 mld. | |
-42,56% | 11,61 mld. | |
+6,89% | 8,83 mld. | |
-10,53% | 7,94 mld. |